What Happened?
San Francisco , CA-based UNITY Biotechnology Appointed Keith Leonard as Chief Executive Officer
About the Company
Unity Biotechnology is developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging. UNITY`s initial focus is on creating senolytic medicines to selectively eliminate senescent cells and thereby treat age-related diseases, such as osteoarthritis, eye diseases and pulmonary diseases.
About the Person
Keith Leonard is Executive Chairman at UNITY Biotechnology. Previously, Keith held various senior HR leadership roles in the industry.
Info Source
News
Short Profile